Gene: COLGALT1
Official Full Name: collagen beta(1-O)galactosyltransferase 1provided by HGNC
Gene Summary: The protein encoded by this gene is one of two enzymes that transfers galactose moieties to hydroxylysine residues of collagen and mannose binding lectin. This gene is constitutively expressed and encodes a soluble protein that localizes to the endoplasmic reticulum. [provided by RefSeq, Dec 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18609 | COLGALT1 Knockout cell line (HeLa) | Human | COLGALT1 | 1:3~1:6 | Negative | Online Inquiry |
KO18610 | COLGALT1 Knockout cell line (HCT 116) | Human | COLGALT1 | 1:2~1:4 | Negative | Online Inquiry |
KO18611 | COLGALT1 Knockout cell line (HEK293) | Human | COLGALT1 | 1:3~1:6 | Negative | Online Inquiry |
KO18612 | COLGALT1 Knockout cell line (A549) | Human | COLGALT1 | 1:3~1:4 | Negative | Online Inquiry |
COLGALT1 Gene Knockout Cell Lines are sophisticated cellular models engineered to lack the COLGALT1 gene, which encodes collagen beta(1-O)-galactosyltransferase 1, an enzyme integral to collagen synthesis and modification. These cell lines serve as vital tools in understanding the cellular and molecular mechanisms underlying various fibrotic diseases, musculoskeletal disorders, and tissue regeneration processes. By providing an experimental platform that lacks functional COLGALT1, researchers can investigate the phenotypic and biochemical modifications that occur due to the absence of this critical gene.
The primary mechanism by which COLGALT1 gene knockout cell lines operate involves the disruption of proper collagen assembly and maturation. Consequently, these models allow researchers to assess the impact of altered collagen networks on cell behavior, including adhesion, proliferation, and differentiation. The use of these knockout lines can unveil possible compensatory pathways activated in response to the loss of COLGALT1 and facilitate the exploration of novel therapeutic targets for related diseases.
Scientifically, COLGALT1 knockout cell lines are invaluable in both research and clinical settings. They enable deeper investigations into the molecular basis of collagen-related pathologies, providing insights crucial for developing therapeutic interventions. Moreover, these cell lines can aid in drug discovery efforts aimed at fibrotic diseases, enabling the testing of compounds in a relevant biological system.
What sets our COLGALT1 knockout cell lines apart from alternatives is their precise genetic engineering and validation, ensuring reliability and reproducibility in experimental results. Unlike generic cell lines, our products come with extensive characterization data, ensuring quality for researchers who demand rigor in their methodologies.
Offering these advanced biological tools supports a wide range of research initiatives, from basic science to applied clinical research. With our longstanding expertise in genetic modifications and a commitment to innovation, we provide high-quality products that empower scientists and clinicians in their quest to unravel the complexities of collagen biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.